Business Description
iosBio is a UK-based biotechnology company developing a ground-breaking oral platform that could revolutionize the way vaccines are manufactured, distributed and delivered. Our current focus is an oral vaccine for Covid-19, which has started clinical trials, an oral version of the seasonal influenza vaccine in preclinical studies and several further vaccines and therapies in discovery.We believe that the future of immunization – no needles, no healthcare professionals, no queues and no risk of cross infection – is now possible, and we are working to make it a reality.
